rs762898505

Variant names:

Your query was ambiguous. Multiple possible variants found:

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4BP6BS1BS2

The NM_001349338.3(FOXP1):c.13T>C(p.Ser5Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000784 in 1,389,720 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S5Y) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 31)

Exomes 𝑓: 0.000074 ( 0 hom. )

Consequence

FOXP1
NM_001349338.3 missense

Scores

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 8.37

Publications

2 publications found

Variant links:

Genes affected

FOXP1 (HGNC:3823): (forkhead box P1) This gene belongs to subfamily P of the forkhead box (FOX) transcription factor family. Forkhead box transcription factors play important roles in the regulation of tissue- and cell type-specific gene transcription during both development and adulthood. Forkhead box P1 protein contains both DNA-binding- and protein-protein binding-domains. This gene may act as a tumor suppressor as it is lost in several tumor types and maps to a chromosomal region (3p14.1) reported to contain a tumor suppressor gene(s). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]

FOXP1 Gene-Disease associations (from GenCC):

intellectual disability-severe speech delay-mild dysmorphism syndrome
Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Illumina, G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
congenital heart disease
Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

FOXP1 links:

ENSG00000285708 (HGNC:):

ENSG00000285708 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4

Computational evidence support a benign effect (MetaRNN=0.4137423).

BP6

Variant 3-71198369-A-G is Benign according to our data. Variant chr3-71198369-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 211036.

BS1

Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000121 (16/132296) while in subpopulation NFE AF = 0.000217 (14/64408). AF 95% confidence interval is 0.000131. There are 0 homozygotes in GnomAd4. There are 8 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.

BS2

High AC in GnomAd4 at 16 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
FOXP1	NM_001349338.3 link	c.13T>C	p.Ser5Pro	missense_variant	Exon 6 of 21	ENST00000649528.3	NP_001336267.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
FOXP1	ENST00000649528.3 link	c.13T>C	p.Ser5Pro	missense_variant	Exon 6 of 21		NM_001349338.3	ENSP00000497369.1		Q9H334-1
ENSG00000285708	ENST00000647725.1 link	c.13T>C	p.Ser5Pro	missense_variant	Exon 11 of 26			ENSP00000497585.1

Frequencies

GnomAD3 genomes

AF:

0.000121

AC:

AN:

132296

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.00

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.000184

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.000217

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.0000717

AC:

AN:

251072

AF XY:

0.0000957

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.0000867

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.000123

Gnomad OTH exome

AF:

0.00

GnomAD4 exome

AF:

0.0000740

AC:

AN:

1257424

Hom.:

Cov.:

AF XY:

0.0000882

AC XY:

AN XY:

623602

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

27676

American (AMR)

AF:

0.000104

AC:

AN:

38548

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

18530

East Asian (EAS)

AF:

0.00

AC:

AN:

20860

South Asian (SAS)

AF:

0.0000118

AC:

AN:

84452

European-Finnish (FIN)

AF:

0.0000282

AC:

AN:

35448

Middle Eastern (MID)

AF:

0.000425

AC:

AN:

4702

European-Non Finnish (NFE)

AF:

0.0000796

AC:

AN:

980300

Other (OTH)

AF:

0.000149

AC:

AN:

46908

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.462

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.000121

AC:

AN:

132296

Hom.:

Cov.:

AF XY:

0.000128

AC XY:

AN XY:

62496

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

35864

American (AMR)

AF:

0.000184

AC:

AN:

10856

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3346

East Asian (EAS)

AF:

0.00

AC:

AN:

3930

South Asian (SAS)

AF:

0.00

AC:

AN:

3932

European-Finnish (FIN)

AF:

0.00

AC:

AN:

7036

Middle Eastern (MID)

AF:

0.00

AC:

AN:

248

European-Non Finnish (NFE)

AF:

0.000217

AC:

AN:

64408

Other (OTH)

AF:

0.00

AC:

AN:

1796

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.522

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.000150

Hom.:

ExAC

AF:

0.0000659

AC:

EpiCase

AF:

0.000273

EpiControl

AF:

0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Uncertain:3Benign:2

Revision: criteria provided, conflicting classifications

LINK: link

Submissions by phenotype

not provided

Uncertain:1Benign:2

Jan 08, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Oct 01, 2022

CeGaT Center for Human Genetics Tuebingen

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

FOXP1: PP3, BS2 -

Jan 27, 2020

GeneDx

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Reported in individual with intellectual disability who inherited variant from parent; however, variant also seen in matched controls and clinical information not provided on parents (Horn et al., 2010); This variant is associated with the following publications: (PMID: 20848658) -

not specified

Uncertain:1

Dec 29, 2014

Genetic Services Laboratory, University of Chicago

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

FOXP1-related disorder

Uncertain:1

Jan 30, 2023

PreventionGenetics, part of Exact Sciences

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

The FOXP1 c.13T>C variant is predicted to result in the amino acid substitution p.Ser5Pro. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.012% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-71247520-A-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

AlphaMissense

Benign

0.19

BayesDel_addAF

Pathogenic

0.19

BayesDel_noAF

Pathogenic

0.27

CADD

Uncertain

(source)

DANN

Uncertain

1.0

DEOGEN2

Uncertain

0.63

D;.;D;.;D;.;.;.;.;D;.;.;D;.;D;.;.;T;.;.;.;.;.;.;.;.;.;.;.

Eigen

Pathogenic

0.74

Eigen_PC

Pathogenic

0.74

FATHMM_MKL

Pathogenic

1.0

LIST_S2

Uncertain

0.94

.;D;.;.;.;.;D;.;D;.;D;D;.;D;D;D;D;D;D;D;.;.;.;D;D;.;D;.;.

M_CAP

Pathogenic

0.35

MetaRNN

Benign

0.41

T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T

MetaSVM

Pathogenic

0.92

MutationAssessor

Uncertain

2.3

M;M;M;M;M;.;.;M;.;M;M;.;M;M;M;.;.;.;.;.;M;M;M;M;.;.;.;.;.

PhyloP100

8.4

PROVEAN

Uncertain

-2.5

D;.;D;D;.;.;.;.;.;D;N;.;.;.;.;D;.;.;.;.;.;D;.;.;.;.;.;.;.

REVEL

Uncertain

0.50

Sift

Pathogenic

0.0

D;.;D;D;.;.;.;.;.;D;D;.;.;.;.;D;.;.;.;.;.;D;.;.;.;.;.;.;.

Sift4G

Uncertain

0.0030

D;D;D;D;.;.;.;.;.;D;D;.;.;.;.;D;.;.;.;.;D;D;.;.;.;.;.;.;.

Polyphen

0.97

D;.;D;.;D;.;.;.;.;D;.;.;D;.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.

Vest4

0.68

MutPred

0.11

Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);Loss of phosphorylation at S5 (P = 0.018);

MVP

0.89

ClinPred

0.38

GERP RS

5.9

PromoterAI

-0.15

Neutral

(source)

RBP_binding_hub_radar

0.0

RBP_regulation_power_radar

2.7

Varity_R

0.74

gMVP

0.49

Mutation Taster

=23/77

disease causing

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over